Influence of lipoprotein lipids, dietary fat and smoking on macrophage degradation of native and oxidized low density lipoprotein
Data up to Jan 2025
Total Citations Per Year
Abstract
References (40)
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
1951 • 319,299 citations
Beyond Cholesterol
1989 • 6,533 citations
The Pathogenesis of Atherosclerosis — An Update
1986 • 4,951 citations
Role of oxidized low density lipoprotein in atherogenesis.
1991 • 2,691 citations
A new method for the direct determination of serum cholesterol.
1953 • 2,530 citations
Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.
1986 • 2,283 citations
A simple fluorometric assay for lipoperoxide in blood plasma
1976 • 2,101 citations
Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids.
1984 • 1,631 citations
Low density lipoprotein undergoes oxidative modification in vivo.
1989 • 1,537 citations
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.
1990 • 1,404 citations
A colorimetric method for estimating serum triglycerides
1968 • 1,137 citations
Malondialdehyde-Altered Protein Occurs in Atheroma of Watanabe Heritable Hyperlipidemic Rabbits
1988 • 757 citations
Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects.
1991 • 727 citations
Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man
1992 • 588 citations
The scavenger cell pathway for lipoprotein degradation: Specificity of the binding site that mediates the uptake of negatively‐charged LDL by macrophages
1980 • 543 citations
Lipoproteins, Cardiovascular Disease, and Death
1981 • 540 citations
Regulation of the activity of the low density lipoprotein receptor in human fibroblasts
1975 • 477 citations
Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size
1992 • 474 citations
Enhanced macrophage degradation of biologically modified low density lipoprotein.
1983 • 469 citations
Low density lipoprotein rich in oleic acid is protected against oxidative modification: implications for dietary prevention of atherosclerosis.
1990 • 461 citations
Food composition tables.
1944 • 457 citations
Lipoprotein fractionation.
1973 • 420 citations
Free radicals, reactive oxygen species and human disease: a critical evaluation with special reference to atherosclerosis.
1989 • 380 citations
Labelling of plasma proteins with radioactive iodine
1956 • 379 citations
Supplementation with vitamin E but not beta-carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro. Effect of cigarette smoking.
1992 • 354 citations
Effects of diets rich in monounsaturated fatty acids on plasma lipoproteins—the Jerusalem Nutrition Study: high MUFAs vs high PUFAs
1991 • 343 citations
Effect of dietary monounsaturated and polyunsaturated fatty acids on the susceptibility of plasma low density lipoproteins to oxidative modification.
1992 • 299 citations
Plasma triglyceride determines structure-composition in low and high density lipoproteins.
1984 • 294 citations
A PROPOSED GENETIC MARKER FOR CORONARY HEART DISEASE RISK
1990 • 186 citations
Lipoproteins, cardiovascular disease, and death. The Framingham study
1981 • 163 citations
Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients
1991 • 159 citations
Supplementation with Vitamin E but Not Beta-Carotene in Vivo Protects Low Density Lipoprotein from Lipid Peroxidation in Vitro
1992 • 99 citations
Low density lipoprotein metabolism in hypertriglyceridemic and normolipidemic patients with coronary heart disease.
1985 • 65 citations
Effect of probucol treatment on the susceptibility of low density lipoprotein isolated from hypercholesterolemic patients to become oxidatively modified in vitro
1990 • 62 citations
Development of femoral atherosclerosis in hypercholesterolemic patients during treatment with cholestyramine and probucol/placebo: Probucol quantitative regression Swedish trial (PQRST): A status report
1988 • 61 citations
Alteration of plasma low density lipoprotein from smokers
1990 • 47 citations
Abnormal regulation of LDL receptor activity and abnormal cellular metabolism of hypertriglyceridaemic low density lipoprotein: normalization with bezafibrate therapy
1987 • 40 citations
Dopexamine hydrochloride in chronic congestive heart failure with improved cardiac performance without increased metabolic cost
1988 • 32 citations
Plasminogen activator inhibitor activity in various types of endogenous hypertriglyceridemia
1993 • 23 citations
Food composition tables
1987 • 21 citations